To The Moon Alice
I keep seeing a lot of comments or speculation that Covid
To The Moon Alice
Top 10 Most Recent News Articles
High-Grade Copper Spurs Optimism for PolarX in Alaska
Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...
Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks
Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...
Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time
An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...
Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?
Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...
Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band
They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...
Continue Reading
2026 Buy-Side Index Reveals State Market Variance
Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...
Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet
They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...
Continue Reading
Liberty Hill: 50 Years of Grassroots Revolution
Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...
Continue ReadingTop 5 Most Recently Viewed Articles
Rising Wage Gaps Reshape Workforce Dynamics, New Insights
Wage Inequality: An Expanding Challenge for Low-Income Workers Recent research has unveiled troubling trends regarding wage inequality, particularly affecting low-income workers. Reports indicate that while incomes for high earners continue to soar, those at the bottom end of the wage spectrum are struggling to keep pace. This growing disparity raises concerns about...
Continue Reading
Centene Corporation Faces Securities Fraud Legal Action
Centene Corporation Faces New Lawsuit Over Securities Fraud Investors of Centene Corporation, known by the ticker symbol CNC, have found themselves at the center of a securities fraud lawsuit. Recently, a leading law firm announced the initiation of legal action against Centene Corporation and some of its senior executives. This lawsuit stems from alleged violations of...
Continue Reading
Michael Saylor Advocates for U.S. Bitcoin Accumulation Strategy
Michael Saylor's Call for Bitcoin Acquisition Bitcoin has gained significant attention as a revolutionary financial asset, and one of its most vocal proponents is Michael Saylor. The Executive Chairman and co-founder of Strategy (NASDAQ: MSTR) has recently expressed his belief that the U.S. government should actively accumulate Bitcoin (BTC) to tackle national debt and...
Continue Reading
Verastem Oncology's Innovative Approach to Ovarian Cancer Treatment
Revolutionizing Ovarian Cancer Treatment Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing therapies for patients battling cancer, is excited to share pivotal details surrounding the results of its ongoing Phase 2 RAMP 201 trial. This promising clinical trial explores the efficacy of Avutometinib combined with Defactinib in treating...
Continue Reading
MySize Inc. Strategizes AI Expansion Through Key Acquisitions
MySize Inc. Enhances AI Strategy for Retail and Fashion MySize, Inc. (NASDAQ: MYSZ), a leader in AI-powered technology solutions for the retail and fashion sectors, is intensifying its strategic initiative to develop a scalable platform that integrates innovative technologies. The company is keen on identifying and potentially acquiring businesses that align with its...
Continue Reading